Growth Factor Therapy and Autologous Lymph Node Transfer in Lymphedema | Zendy

Markku Lähteenvuo | Zendy; Krista Honkonen | Zendy; Tomi V. Tervala | Zendy; Tuomas Tammela | Zendy; Erkki Suominen | Zendy; Johanna Lähteenvuo | Zendy; Ivana Kholová | Zendy; Kari Alitalo | Zendy; Seppo YläHerttuala | Zendy; Anne Saaristo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Growth Factor Therapy and Autologous Lymph Node Transfer in Lymphedema

Author(s) -

Markku Lähteenvuo,

Krista Honkonen,

Tomi V. Tervala,

Tuomas Tammela,

Erkki Suominen,

Johanna Lähteenvuo,

Ivana Kholová,

Kari Alitalo,

Seppo YläHerttuala,

Anne Saaristo

Publication year - 2011

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.110.965384

Subject(s) - medicine , lymphatic system , lymphedema , lymphangiogenesis , lymph node , vascular endothelial growth factor , lymph , vascular endothelial growth factor c , lymphatic vessel , edema , pathology , surgery , vascular endothelial growth factor a , vegf receptors , cancer , breast cancer , metastasis

Lymphedema after surgery, infection, or radiation therapy is a common and often incurable problem. Application of lymphangiogenic growth factors has been shown to induce lymphangiogenesis and to reduce tissue edema. The therapeutic effect of autologous lymph node transfer combined with adenoviral growth factor expression was evaluated in a newly established porcine model of limb lymphedema.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research